ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 142 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2 | -100.0% | 76,300 | +63.0% | 0.00% | -100.0% |
Q3 2022 | $15,000 | +7.1% | 46,800 | -43.0% | 0.00% | 0.0% |
Q2 2022 | $14,000 | +250.0% | 82,100 | -19.0% | 0.00% | – |
Q1 2022 | $4,000 | +33.3% | 101,300 | +151.4% | 0.00% | – |
Q4 2021 | $3,000 | -76.9% | 40,300 | -26.3% | 0.00% | – |
Q3 2021 | $13,000 | +160.0% | 54,700 | +147.5% | 0.00% | – |
Q2 2021 | $5,000 | 0.0% | 22,100 | -70.2% | 0.00% | – |
Q4 2020 | $5,000 | -97.8% | 74,200 | +44.5% | 0.00% | -100.0% |
Q2 2019 | $224,000 | +833.3% | 51,342 | +99.0% | 0.02% | +800.0% |
Q1 2019 | $24,000 | +140.0% | 25,800 | +8.9% | 0.00% | +100.0% |
Q4 2016 | $10,000 | +900.0% | 23,700 | -21.0% | 0.00% | – |
Q3 2014 | $1,000 | -96.6% | 30,000 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $29,000 | -23.7% | 30,000 | 0.0% | 0.00% | -50.0% |
Q1 2014 | $38,000 | – | 30,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
SFMG, LLC | 62,433 | $334,000 | 0.07% |
Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |